Last $6.25 USD
Change Today 0.00 / 0.00%
Volume 2.5K
CAPR On Other Exchanges
Symbol
Exchange
OTC US
As of 2:35 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

capricor therapeutics inc (CAPR) Snapshot

Open
$6.00
Previous Close
$6.25
Day High
$6.50
Day Low
$6.00
52 Week High
01/22/14 - $17.15
52 Week Low
08/7/13 - $1.40
Market Cap
73.1M
Average Volume 10 Days
2.3K
EPS TTM
$-1.55
Shares Outstanding
11.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CAPRICOR THERAPEUTICS INC (CAPR)

Related News

No related news articles were found.

capricor therapeutics inc (CAPR) Related Businessweek News

No Related Businessweek News Found

capricor therapeutics inc (CAPR) Details

Capricor Therapeutics, Inc., a heart failure biotechnology company, focuses on the development of novel therapeutics to prevent and treat heart diseases. The company’s lead cardiac-derived cells product candidate includes CAP-1002, a proprietary allogeneic adult stem cell therapy, which is in the ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration Phase I/II trials for the treatment of heart damage. It also develops Cenderitide, a novel chimeric natriuretic peptide that is in Phase I/II clinical trials to treat heart failure patients during the post-acute heart failure period, which is the 90-day period immediately after discharge from a hospitalization for acute decompensated heart failure. The company was formerly known as Nile Therapeutics, Inc. and changed its name to Capricor Therapeutics, Inc. as a result of its merger with Capricor, Inc. in November 2013. Capricor Therapeutics, Inc. was founded in 2005 and is based in San Mateo, California.

19 Employees
Last Reported Date: 03/31/14
Founded in 2005

capricor therapeutics inc (CAPR) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $232.3K
Executive Vice President and General Counsel
Total Annual Compensation: $189.4K
Compensation as of Fiscal Year 2013.

capricor therapeutics inc (CAPR) Key Developments

Capricor Therapeutics, Inc. Presents at Alliance for Regenerative Medicine 2nd Annual Regen Med Investor Day, Mar-26-2014 01:45 PM

Capricor Therapeutics, Inc. Presents at Alliance for Regenerative Medicine 2nd Annual Regen Med Investor Day, Mar-26-2014 01:45 PM. Venue: Metropolitan Club, One East 60th Street, New York, NY 10022, United States. Speakers: Linda Marban, Co-Founder, Chief Executive Officer and Director.

Capricor Therapeutics, Inc. Presents at 26th Annual ROTH Conference, Mar-10-2014 04:00 PM

Capricor Therapeutics, Inc. Presents at 26th Annual ROTH Conference, Mar-10-2014 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Linda Marban, Co-Founder, Chief Executive Officer and Director.

Capricor Therapeutics, Inc. Announces Auditor Change

On January 17, 2014, Capricor Therapeutics approved the dismissal of Crowe Horwath LLP as Capricor Therapeutics' independent registered public accounting firm. On the same day engaged Rose, Snyder & Jacobs LLP as Capricor Therapeutics' new independent registered public accounting firm.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CAPR:US $6.25 USD 0.00

CAPR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aastrom Biosciences Inc $3.51 USD -0.12
Athersys Inc $2.74 USD +0.11
Cytomedix Inc $0.56 USD -0.0295
Cytori Therapeutics Inc $2.35 USD 0.00
NeoStem Inc $6.50 USD -0.16
View Industry Companies
 

Industry Analysis

CAPR

Industry Average

Valuation CAPR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 454.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 133.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAPRICOR THERAPEUTICS INC, please visit www.capricor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.